A primer on anaerobic bacteria and anaerobic infections for the uninitiated

Infection

Volumn 27, Issue 3, 1999, Pages 159-165

  Olsen, Ingar ^a   Solberg, C O ^d   Finegold, S M ^c   Solberg, C A ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CHLORAMPHENICOL; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; METRONIDAZOLE; NITROIMIDAZOLE; ORNIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; TAZOBACTAM; THIAMPHENICOL;

ANAEROBIC BACTERIUM; ANAEROBIC INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; CLOSTRIDIUM; CULTURE MEDIUM; DEBRIDEMENT; GASTROINTESTINAL INFECTION; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; LABORATORY TEST; MOUTH INFECTION; NONHUMAN; ODOR; PARENTERAL DRUG ADMINISTRATION; PATHOGENESIS; REVIEW; SKIN INFECTION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; HUMANS; INCIDENCE;

EID: 0032998753     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02561521     Document Type: Review

References (15)

1. 1. Allen, S. D., Siders, J. A., Marler, L. M.: Current issues and problems in dealing with anaerobes in the clinical laboratory. Clin. Lab. Med. 15 (1995) 333-364.
2. 2. Finegold, S. M.: Anaerobic infections in humans: an overview. Anaerobe 1 (1995) 3-9.
3. 3. Finegold, S. M., George, W. L. (eds.): Anaerobic infections in humans. Academic Press, San Diego 1989.
4. 4. Finegold, S. M., Wexler, H. M.: Present status of therapy for anaerobic infections. Clin. Infect. Dis. 23 (Suppl. 1) (1996) S9-S14.
5. 5. Rosenblatt, J. E., Brook, I.: Clinical relevance of susceptibility testing of anaerobic bacteria. Clin. Infect. Dis. 16 (Suppl. 4) (1993) 446-448.
6. 6. NCCLS: Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard. 4th ed. NCCLS document M11-A4. NCCLS, Wayne, PA 1997.
7. 7. Goldstein, E. J. C.: Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6858a) in the treatment of anaerobic infections: review of current information on efficacy and safety. Clin. Infect. Dis. 23 (Suppl. 1) (1996) S25-S30.
8. 8. Hedberg, M., Nord, C. E.: Beta-lactam resistance in anaerobic bacteria: a review. J. Chemother. 8 (1996) 3-16.
9. 9. Salyers, A. A., Shoemaker, N. B.: Resistance gene transfer in anaerobes: new insights, new problems. Clin. Infect. Dis. 23 (Suppl. 1) (1996) S36-S43.
10. 10. Finegold, S.M., Jousimies-Somer, H.R., Wexler, H.M.: Current perspectives on anaerobic infections: diagnostic approaches. Infect. Dis. Clin. North Am. 7 (1993) 257-275.
11. 11. Summanen, P., Baron, E. J., Citron, D. M., Strong, C., Wexler, H. M., Finegold, S. M.: Wadsworth anaerobic bacteriology manual. 5th ed. Star Publishing Co., Belmont 1993.
12. 12. Citron, D. M., Baron, E. J., Finegold, S. M., Goldstein, E. J.: Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species. J. Clin. Microbiol. 28 (1990) 2220-2223.
13. 13. Arzese, A., Minisini, R., Botta, G. A.: Evaluation of an automated system for identification of anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 13 (1994) 135-141.
14. 14. Paster, B. J., Dewhirst, F. E., Olsen, I., Fraser, G. J., Socransky, S. S.: Gram-negative anaerobes: 16S rRNA sequences, phylogeny and DNA probes. In: Duerden, B. I., Wade, W. G., Brazier, J. S., Eley, A., Wren, B., Hudson, M. J. (eds.): Medical and dental aspects of anaerobes. Science Reviews, Northwood 1995. pp. 373-386.
15. 15. Möller, Å. J. R.: Microbiological examination of root canals and periapical tissues of human teeth. Odont. Tidskr. 74 (1966) 1-365.